Statistics for Antisense oligonucleotide exon-skipping as a therapeutic approach for Mucolipidosis type II a/b: in vitro and in vivo studies
Total visits
| views | |
|---|---|
| Antisense oligonucleotide exon-skipping as a therapeutic approach for Mucolipidosis type II a/b: in vitro and in vivo studies | 21 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| OTS 2021 Presentation LM.pdf | 20 |
Top country views
| views | |
|---|---|
| United States | 8 |
| Portugal | 7 |
| China | 2 |
| Spain | 1 |
| Hong Kong SAR China | 1 |
| Poland | 1 |
| Singapore | 1 |